These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6104635)

  • 1. Electrophysiological characteristics of tobanum, a new beta receptor blocking agent.
    Solti F; Czakó E
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):229-32. PubMed ID: 6104635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrical properties of a new beta-blocker agent, tertatolol, in man].
    Touboul P; Atallah G; Kirkorian G; Lamaud M; Moleur P
    Therapie; 1983; 38(4):371-8. PubMed ID: 6139893
    [No Abstract]   [Full Text] [Related]  

  • 3. [Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)].
    Kanno M; Nakaya H; Hattori Y; Izumi T; Nishimura T; Sakai K; Abiko Y
    Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):621-32. PubMed ID: 6111522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical electrophysiological properties of penbutolol: a non-selective beta-blocking agent.
    von Leitner ER; Biamino G
    Eur J Cardiol; 1980; 12(2):121-8. PubMed ID: 7439238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Pharmacological studies with LL 21-945, a new beta-adrenoceptor blocking agent with a long duration of action.
    Clark BJ; Saameli K; Troxler F
    Br J Pharmacol; 1974 Sep; 52(1):123P. PubMed ID: 4155983
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs.
    Jaillon P; Hecklé J; Weissenburger J; Cheymol G
    J Pharmacol Exp Ther; 1980 Feb; 212(2):347-53. PubMed ID: 6101348
    [No Abstract]   [Full Text] [Related]  

  • 7. Electrophysiological characteristics of lorcainide, a new antiarrhythmic drug.
    Solti F; Czakó E; Szatmáry L
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):26-9. PubMed ID: 3957486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of blocking the beta-adrenergic receptors on ventricular diastole and on the systole of the left atrium in normal subjects. (Evaluation with the polygraphic method)].
    Vitale P; Mazza F; Jacono A
    Minerva Cardioangiol; 1971 Aug; 19(8):418-23. PubMed ID: 4397763
    [No Abstract]   [Full Text] [Related]  

  • 9. [Electrophysiologic effects of 30,356 RP in man].
    Touboul P; Gressard A; Atallah G; Chatelain MT
    Therapie; 1978; 33(3):277-85. PubMed ID: 684681
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of electrophysiological effects of betaxolol].
    Ponsonnaille J; Citron B; Trolese JF; Serignat B; Gras H
    Ann Cardiol Angeiol (Paris); 1987 Mar; 36(3):149-53. PubMed ID: 2882723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels and electrophysiological effects of acebutolol (M & B 17.803) in the dog heart in situ.
    Amlie JP; Lessum S; Collins RF; Landmark K
    Acta Pharmacol Toxicol (Copenh); 1977 Mar; 40(3):378-88. PubMed ID: 190859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
    Fujiki A; Tani M; Mizumaki K; Shimono M; Inoue H
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of beta-blockade and the non-specific effect of bucumolol, a beta-adrenergic blocking agent, on atrioventricular conduction in anesthetized dogs.
    Nakayama K; Oshima T; Koike H
    Arch Int Pharmacodyn Ther; 1981 Nov; 254(1):145-56. PubMed ID: 6121536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologically determined quinidine-like actions of a beta-adrenergic blocking agent, 1-(7-indenyloxy)-3-isopropylaminopropane-2-ol hydrochloride (YB-2).
    Tatsuno H; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1976 Jun; 221(2):197-207. PubMed ID: 9035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic properties of intravenous Tenormine in man.
    Di Biase M; Favale S; Rizzon P
    Eur J Cardiol; 1979 Apr; 9(4):333-42. PubMed ID: 34520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The electrophysiological evaluation of intravenous acebutolol, a beta-blocking drug.
    Marrott PK; Ruttley MS; Jenkins PM; Muir JR
    Eur J Cardiol; 1977 Oct; 6(2):117-30. PubMed ID: 913484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrophysiologic effects of lorcainide (R 15889) in man].
    Touboul P; Atallah G; Kirkorian G
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1333-40. PubMed ID: 6797372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical-electrophysiologic studies on the actions of the anti-arrhythmic substance AWD-G256 in man].
    Volkmann H; Hoffmann A; Kühnert H; Dannberg G; Heinke M; Reimann I; Marschner JP; Farker K
    Pharmazie; 1993 May; 48(5):380-5. PubMed ID: 8327568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of Tobanum on the electrophysiology of the heart].
    Tarján J; Rostás L; Wagner G; Józan M; Lascsik L
    Orv Hetil; 1981 Dec; 122(49):3005-8. PubMed ID: 6120494
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of atropine on atrial refractoriness and its dispersion in humans.
    Michelucci A; Padeletti L; Fradella GA; Molina Lova R; Monizzi D; Giomi A; Fantini F
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):254-8. PubMed ID: 6746148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.